Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Biothera Presents Pharmacokinetic Data for its Cancer Immunotherapy Imprime PGG

ATLANTA — March 21, 2014 —Pharmacokinetic (PK) data supporting the dose and schedule regimens of Biothera’s phase 3 cancer immunotherapy Imprime PGG® are being presented at the American Society for Clinical Pharmacology and Therapeutics Annual Meeting in Atlanta this week. The results are based on population pharmacokinetic data generated from four clinical trials that included […]

Therapeutic Area: Oncology/Hematology
More Info

Certara Conducts Model-based Meta-analysis to Compare Efficacy, Tolerability of Two Pain Medications

Data published in Pain and Therapy compare tramadol with tapentadol ST. LOUIS, MO – Feb. 24, 2014 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced today that its model-based meta-analysis comparing tramadol with tapentadol for the treatment of chronic nonmalignant […]

Therapeutic Area: Central Nervous System
More Info

Medivir AB Chooses Certara’s D360 as its Global Drug Discovery Platform

D360™ will provide enhanced data access and visualization, permitting closer collaboration between Medivir’s discovery scientists ST. LOUIS, MO – Jan. 27, 2014 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Medivir AB, a Swedish pharmaceutical company that focuses […]

Solution: Scientific Informatics
More Info

Professor Geoff Tucker Named President-Elect, International Society for the Study of Xenobiotics

ST. LOUIS, MO – Jan. 21, 2014 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Professor Geoff Tucker, its vice president of translational sciences, and co-founder of Simcyp™ and head of its consultancy, has been named president-elect of […]

More Info

Arsenal Capital Partners Acquires Leading Model-based Drug Development Company Certara

NEW YORK, NY- Dec. 19, 2013 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies, announced today the acquisition of Certara, the leading provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical research and development market. Certara […]

More Info

Certara Partners With Thomson Reuters to Expand Data Access Through Its D360 Platform

Certara customers will now be able to view curated life sciences content from Thomson Reuters Cortellis™ alongside their proprietary scientific data ST. LOUIS, MO – October 22, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that it is […]

Solution: Scientific Informatics
More Info

Boehringer Ingelheim Selects Certara’s D360 as its Global Drug Discovery Platform

D360™ will permit chemical structure and related biological property data to be shared between global sites. ST. LOUIS, MO – Oct. 17, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that the pharmaceutical company Boehringer Ingelheim has chosen […]

Solution: Scientific Informatics
More Info
Learn More LinkedIn Twitter Facebook Email